Home › NDC Lookup › RxCUI directory › RxCUI 998685

Acebutolol 400 MG Oral Capsule — RxCUI 998685

RxNorm drug concept · Semantic clinical drug
RxCUI 998685 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI998685
Official nameAcebutolol 400 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asacebutolol (as acebutolol HCl) 400 MG Oral Capsule; acebutolol HCl 400 MG Oral Capsule
FDA products mapped8
Package NDCs mapped14
Reported Medicaid activity (SDUD)3,016 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acebutolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acebutolol is most commonly prescribed for one of two things: high blood pressure (hypertension) or abnormal heartbeats called ventricular premature beats. For blood pressure, it w...
  • What exactly is acebutolol being used to treat in my case?
  • Please don't stop it suddenly — this is one of the most important things to know about acebutolol. Stopping abruptly, especially if you have any heart or artery disease, can cause...
  • Can I just stop taking acebutolol if I feel fine or don't like the side effects?
📖 Read our full Acebutolol guide →

🕸️ Concept Web — How Acebutolol 400 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acebutolol 400 MG Oral Capsule RxCUI 998685

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Acebutolol 149
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acebutolol Oral Capsule 370505
    • Acebutolol Oral Product 1153659
    • Acebutolol Pill 1153660
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acebutolol 400 MG 328700

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acebutolol 400 MG SCDC · 328700
  • Acebutolol Oral Capsule SCDF · 370505
  • Acebutolol Oral Product SCDG · 1153659
  • Acebutolol Pill SCDG · 1153660

📦 FDA Products & Package NDCs

8 products · 14 package NDCs
14 package NDCs map to RxCUI 998685 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51407-0666-01 100 CAPSULE in 1 BOTTLE (51407-666-01) Acebutolol Hydrochloride Golden State Medical Supply, Inc. 2022-08-01
51407-0667-01 100 CAPSULE in 1 BOTTLE (51407-667-01) Acebutolol Hydrochloride Golden State Medical Supply, Inc. 2022-08-01
53746-0669-01 100 CAPSULE in 1 BOTTLE (53746-669-01) Acebutolol Hydrochloride Amneal Pharmaceuticals of New York LLC 2009-12-01
53746-0669-05 500 CAPSULE in 1 BOTTLE (53746-669-05) Acebutolol Hydrochloride Amneal Pharmaceuticals of New York LLC 2009-12-01
53746-0670-01 100 CAPSULE in 1 BOTTLE (53746-670-01) Acebutolol Hydrochloride Amneal Pharmaceuticals of New York LLC 2009-12-01
53746-0670-05 500 CAPSULE in 1 BOTTLE (53746-670-05) Acebutolol Hydrochloride Amneal Pharmaceuticals of New York LLC 2009-12-01
53746-0670-30 30 CAPSULE in 1 BOTTLE (53746-670-30) Acebutolol Hydrochloride Amneal Pharmaceuticals of New York LLC 2009-12-01
62559-0255-01 100 CAPSULE in 1 BOTTLE (62559-255-01) Acebutolol Hydrochloride ANI Pharmaceuticals, Inc. 2022-07-25
62559-0256-01 100 CAPSULE in 1 BOTTLE (62559-256-01) Acebutolol Hydrochloride ANI Pharmaceuticals, Inc. 2022-07-25
65162-0669-10 100 CAPSULE in 1 BOTTLE (65162-669-10) Acebutolol Hydrochloride Amneal Pharmaceuticals LLC 2009-12-01
65162-0669-50 500 CAPSULE in 1 BOTTLE (65162-669-50) Acebutolol Hydrochloride Amneal Pharmaceuticals LLC 2009-12-01
65162-0670-03 30 CAPSULE in 1 BOTTLE (65162-670-03) Acebutolol Hydrochloride Amneal Pharmaceuticals LLC 2009-12-01
65162-0670-10 100 CAPSULE in 1 BOTTLE (65162-670-10) Acebutolol Hydrochloride Amneal Pharmaceuticals LLC 2009-12-01
65162-0670-50 500 CAPSULE in 1 BOTTLE (65162-670-50) Acebutolol Hydrochloride Amneal Pharmaceuticals LLC 2009-12-01
Observed labelers: Amneal Pharmaceuticals LLC (5) · Amneal Pharmaceuticals of New York LLC (5) · ANI Pharmaceuticals, Inc. (2) · Golden State Medical Supply, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.